Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M2,523Revenue (TTM) $M87.0Net Margin (%)303Altman Z-Score6.4
Enterprise Value $M2,615EPS (TTM) $12.3Operating Margin %44.9Piotroski F-Score6
P/E(ttm)9.9Beneish M-Score0.5Pre-tax Margin (%)51.7Higher ROA y-yY
Price/Book6.510-y EBITDA Growth Rate %--Quick Ratio10.7Cash flow > EarningsN
Price/Sales30.25-y EBITDA Growth Rate %--Current Ratio10.9Lower Leverage y-yY
Price/Free Cash Flow80.7y-y EBITDA Growth Rate %109ROA % (ttm)58.8Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)120Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M20.8ROIC % (ttm)118Gross Margin Increase y-yY

Gurus Latest Trades with LGND

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
LGNDJoel Greenblatt 2016-03-31 Buy 0.03%$85.79 - $108.42
($97.41)
$ 122.5626%New holding21,822
LGNDKen Fisher 2015-12-31 Reduce$85.69 - $111.85
($99.19)
$ 122.5624%Reduce -0.14%70,583
LGNDKen Fisher 2015-09-30 Reduce$82.1 - $111.25
($97.26)
$ 122.5626%Reduce -12.31%70,683
LGNDKen Fisher 2015-06-30 Reduce$75.67 - $100.9
($87.3)
$ 122.5640%Reduce -1.59%80,608
LGNDJoel Greenblatt 2015-03-31 Sold Out -0.0016%$51.54 - $77.11
($61.42)
$ 122.56100%Sold Out0
LGNDJoel Greenblatt 2014-12-31 Reduce-0.26%$42.36 - $57.96
($52.25)
$ 122.56135%Reduce -99.32%3,766
LGNDKen Fisher 2014-12-31 Add0.01%$42.36 - $57.96
($52.23)
$ 122.56135%Add 132.31%81,908
LGNDJoel Greenblatt 2014-09-30 Add0.23%$46.99 - $64.52
($53.04)
$ 122.56131%Add 894.83%552,053
LGNDJoel Greenblatt 2014-06-30 Buy 0.04%$59.74 - $70.19
($65.09)
$ 122.5688%New holding55,492
LGNDKen Fisher 2014-06-30 Buy $59.74 - $70.19
($65.09)
$ 122.5688%New holding36,908
LGNDJoel Greenblatt 2014-03-31 Sold Out -0.02%$51.52 - $79.58
($66.37)
$ 122.5685%Sold Out0
LGNDJoel Greenblatt 2013-12-31 Add0.01%$44.86 - $57.95
($52.33)
$ 122.56134%Add 124.95%13,803
LGNDJoel Greenblatt 2013-09-30 Buy 0.01%$38.69 - $49.66
($45.21)
$ 122.56171%New holding6,136
LGNDGeorge Soros 2011-09-30 Sold Out -0.0017%$10.89 - $15.95
($13.18)
$ 122.56830%Sold Out0
LGNDGeorge Soros 2011-06-30 Buy $9.56 - $12.02
($10.55)
$ 122.561062%New holding10,000
LGNDGeorge Soros 2009-12-31 Sold Out $9.96 - $14.16
($12.16)
$ 122.56908%Sold Out0
LGNDGeorge Soros 2009-09-30 Buy $13.74 - $18.9
($16.15)
$ 122.56659%New holding4,483
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

LGND is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


LGND: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Herman Melanie JDirector of Accounting 2016-05-18Sell334$120.50.56view
Aryeh JasonDirector 2016-05-06Sell25,000$119.21.66view
KOZARICH JOHN WDirector 2016-05-02Sell1,000$121.57-0.32view
KOZARICH JOHN WDirector 2016-04-06Sell5,000$1155.37view
FOEHR MATTHEW WPresident and COO 2016-03-17Sell6,400$96.725.32view
Aryeh JasonDirector 2016-03-08Sell6,129$101.1819.77view
HIGGINS JOHN LCEO 2016-03-07Sell10,833$102.4718.26view
KOZARICH JOHN WDirector 2016-01-20Sell1,666$94.9427.64view
Aryeh JasonDirector 2015-11-11Sell3,000$101.4919.4view
Herman Melanie JDirector of Accounting 2015-11-11Sell7,719$10119.98view

Quarterly/Annual Reports about LGND:

News about LGND:

Articles On GuruFocus.com
RS Investment Increases Holdings in Ulta Salon, Noble Energy and Fortune Brands Dec 23 2015 
Dan Loeb Sees Opportunity in Latest Activist Target Baxter International Aug 06 2015 
Dan Loeb Sees Opportunity in Latest Activist Target Baxter International Aug 06 2015 
Ligand Pharmaceuticals - Severe competitive threat to key royalty program and “going concern” ri Jun 19 2014 
5 Hot Stocks to Consider Now Mar 30 2012 
Ligand Pharmaceuticals Inc. Reports Operating Results (10-Q) Aug 05 2010 
Ligand Pharmaceuticals Inc. Reports Operating Results (10-Q) May 05 2010 
Ligand Pharmaceuticals Inc. Reports Operating Results (10-Q) Nov 09 2009 
Ligand Pharmaceuticals Inc. Reports Operating Results (10-Q) Aug 04 2009 

More From Other Websites
LIGAND PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers, Submission... May 25 2016
LIGAND PHARMACEUTICALS INC Financials May 18 2016
VKTX: Phase 2 Study of VK5211 for Hip Fracture Ongoing; Phase 2 Study of VK2809 for... May 16 2016
Intec Pharma to Nominate Dr. John W. Kozarich as Chairman of the Board of Directors May 16 2016
ETF’s with exposure to Ligand Pharmaceuticals, Inc. : May 9, 2016 May 09 2016
LIGAND PHARMACEUTICALS INC Files SEC form 8-K/A, Entry into a Material Definitive Agreement,... May 09 2016
Ligand Pharmaceuticals, Inc. :LGND-US: Earnings Analysis: Q1, 2016 By the Numbers May 05 2016
Ligand (LGND) Tops Q1 Earnings, Revenues, Updates View May 05 2016
IBD 50: Ligand Pharma Beats Q1 Estimates, Buys Device Royalties May 04 2016
Ligand (LGND) Beats Q1 Earnings and Revenue Estimates May 04 2016
Ligand Pharmaceuticals Q1 Adjusted Earnings Beat May 04 2016
Q1 2016 Ligand Pharmaceuticals Inc Earnings Release - Before Market Open May 04 2016
Ligand tops 1Q revenue forecasts May 04 2016
Ligand tops 1Q revenue forecasts May 04 2016
LIGAND PHARMACEUTICALS INC Files SEC form 8-K, Entry into a Material Definitive Agreement May 04 2016
Ligand Reports First Quarter 2016 Financial Results May 04 2016
Ligand Acquires Portfolio of Synthetic Royalty and Milestone Rights from CorMatrix® Cardiovascular... May 04 2016
Biotech Stocks Earnings Preview: REGN, LGND, ECYT & More May 03 2016
Ligand (LGND) Q1 Earnings: What's in Store for the Stock? May 02 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)